학술논문
A novel HCV NS3 protease mutation selected by combination treatment of the protease inhibitor boceprevir and NS5B polymerase inhibitors
Document Type
Article
Author
Source
In Antiviral Research November 2009 84(2):178-184
Subject
Language
ISSN
0166-3542